These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2197718)

  • 21. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 22. Sulphonylurea in combination with insulin therapy: does it make sense? A review.
    Kyllästinen M
    Ann Clin Res; 1983; 15 Suppl 37():29-32. PubMed ID: 6383182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin in the early management of diabetic complications.
    Miles JM
    J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of diabetes mellitus in "secondary failure of sulfonylurea compounds"].
    Bachmann W
    Med Klin (Munich); 1987 Jun; 82(14):491-4. PubMed ID: 3302644
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical use of oral sulfonylureas in the management of non-insulin dependent diabetes mellitus (NIDDM).
    Ponte CD
    W V Med J; 1990 Oct; 86(10):455-8. PubMed ID: 2238629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possibilities and limits of oral diabetes therapy].
    Bruneder H
    Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract]   [Full Text] [Related]  

  • 27. Secondary failure to sulfonylureas in NIDDM. Are sulfonylureas still useful?
    Menon KN; Seshadri MS
    J Assoc Physicians India; 1990 Aug; 38(8):533-4. PubMed ID: 2123182
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sulfonylureas].
    Sagreira L
    Acta Med Port; 1989 Sep; Suppl 1():9S-13S. PubMed ID: 2694782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating type 2 diabetes: targeting the many causative factors.
    Sutherland JE; Hoehns JD
    J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
    [No Abstract]   [Full Text] [Related]  

  • 30. Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes.
    Raskin P
    Diabetes Metab Res Rev; 2008; 24(1):3-13. PubMed ID: 17968971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination insulin-sulfonylurea therapy in type II diabetes mellitus.
    Allen BT; Feinglos MN
    South Med J; 1987 Oct; 80(10):1285-9. PubMed ID: 3310252
    [No Abstract]   [Full Text] [Related]  

  • 32. [Triple oral therapy in type 2 diabetes].
    Scheen AJ
    Rev Med Suisse; 2005 Aug; 1(30):1942, 1944-6, 1948. PubMed ID: 16200937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycaemic control in type 2 diabetes.
    Campbell A
    Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination therapy for type 2 diabetes.
    Bell DS
    Am Fam Physician; 2001 Dec; 64(11):1812, 1814. PubMed ID: 11764861
    [No Abstract]   [Full Text] [Related]  

  • 35. [Controversial aspects regarding metformin in type 2 diabetic patient: reduction of late complications in early, single drug administration; increased risk of death in later administration in combination with sulfonylurea compounds].
    Ritzmann P
    Praxis (Bern 1994); 1999 Aug; 88(33):1330-1. PubMed ID: 10483287
    [No Abstract]   [Full Text] [Related]  

  • 36. Drugs for type 2 diabetes.
    Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
    [No Abstract]   [Full Text] [Related]  

  • 37. Roundtable. Blueprint for conversion of patients on metformin and sulfonylurea to Glucovance.
    Roselli A; Hayes JD; Seidner R; Marchione V; Snyder CM; Mayes K; Stiernberg CM; Milgram L
    Manag Care; 2001 Feb; 10(2 Suppl):17-21. PubMed ID: 11729404
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination therapy for NIDDM: has its time arrived?
    Menke J
    S D J Med; 1995 Aug; 48(8):246-7. PubMed ID: 7569874
    [No Abstract]   [Full Text] [Related]  

  • 39. Combining insulin and sulfonylurea. A therapeutic option for type II diabetes.
    Riddle MC
    Postgrad Med; 1992 Aug; 92(2):89-90, 95-6, 99-102. PubMed ID: 1495886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined insulin-sulfonylurea treatment of type II diabetes.
    Bingham PR; Riddle MC
    Diabetes Educ; 1989; 15(5):450-5. PubMed ID: 2673707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.